Cargando…

Epothilones in epithelial ovarian, fallopian tube, or primary peritoneal cancer: a systematic review

Ovarian cancer is the most lethal gynecologic malignancy; consequently, there is a need for effective therapies. Epothilones are microtubule-stabilizing agents that inhibit cell growth. Currently, patupilone and its four synthetic derivatives ixabepilone, BMS-310705, sagopilone, 20-desmethyl-20-meth...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zagouri, Flora, Sergentanis, Theodoros N, Chrysikos, Dimosthenis, Dimopoulos, Meletios-Athanassios, Bamias, Aristotle
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2015
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4550178/ https://www.ncbi.nlm.nih.gov/pubmed/26316786 http://dx.doi.org/10.2147/OTT.S77342

Ejemplares similares

Bevacizumab toxicity in heavily pretreated recurrent epithelial ovarian, fallopian tube, and primary peritoneal cancers
por: Martin, Jovana Y., et al.
Publicado: (2016)

Reclassification of BRCA1 and BRCA2 variants found in ovarian epithelial, fallopian tube, and primary peritoneal cancers
por: Ha, Hyeong In, et al.
Publicado: (2020)

Discussing maintenance therapy for ovarian, peritoneal, and fallopian tube cancers
por: Mercier, Ann Marie, et al.
Publicado: (2023)

Skin metastases in epithelial ovarian and fallopian tube carcinoma
por: Otsuka, Isao, et al.
Publicado: (2017)

Profile of trebananib (AMG386) and its potential in the treatment of ovarian cancer
por: Liontos, Michalis, et al.
Publicado: (2014)

Second Primary Ovarian Epithelial, Fallopian Tube, and Primary Peritoneal Cancers after Breast Cancer Diagnosis: Korea Central Cancer Registry
por: Ha, Hyeong In, et al.
Publicado: (2021)

Primary Papillary Adenocarcinoma of the Fallopian Tube with Ovarian Metastasis
por: Marwah, Nisha, et al.
Publicado: (2012)

Management of the Elderly Patients with High-Grade Serous Ovarian Cancer in the REAL-WORLD Setting
por: Liontos, Michalis, et al.
Publicado: (2021)

Clinical relevance of circulating tumor cells in ovarian, fallopian tube and peritoneal cancer
por: Banys-Paluchowski, Malgorzata, et al.
Publicado: (2020)

Role of histological type on surgical outcome and survival following radical primary tumour debulking of epithelial ovarian, fallopian tube and peritoneal cancers
por: Braicu, E-I, et al.
Publicado: (2011)

Potential predictors for chemotherapeutic response and prognosis in epithelial ovarian, fallopian tube and primary peritoneal cancer patients treated with platinum-based chemotherapy
por: Jeerakornpassawat, Dhammapoj, et al.
Publicado: (2020)

A phase Ib trial of docetaxel, carboplatin and erlotinib in ovarian, fallopian tube and primary peritoneal cancers
por: Vasey, P A, et al.
Publicado: (2008)

Safety and Efficacy of Video Laparoscopic Surgical Debulking of Recurrent Ovarian, Fallopian Tube, and Primary Peritoneal Cancers
por: Nezhat, Farr R., et al.
Publicado: (2012)

Peritoneal Dialysis Catheter−Fallopian Tube Fistula
por: Mandalapu, Rajendra, et al.
Publicado: (2020)

Retrospective analysis of bevacizumab-induced arthralgia and clinical outcomes in ovarian cancer patients. Single center experience
por: Kaparelou, Maria, et al.
Publicado: (2022)

Clinical Perspectives of ERCC1 in Bladder Cancer
por: Koutsoukos, Konstantinos, et al.
Publicado: (2020)

Cancer in pregnancy: disentangling treatment modalities
por: Zagouri, Flora, et al.
Publicado: (2016)

Epithelialization of mouse ovarian tumor cells originating in the fallopian tube stroma
por: Hua, Yuanyuan, et al.
Publicado: (2016)

Outcomes and Prognostic Factors of Patients with Platinum-Resistant or Refractory Epithelial Ovarian Cancer, Fallopian Tube Cancer and Peritoneal Cancer
por: Hamontri, Suttha, et al.
Publicado: (2023)

Evaluation of MET T1010I and MET rs40239 single-nucleotide polymorphisms in triple-negative breast cancer: a case–control study
por: Kalapanida, Despoina, et al.
Publicado: (2019)

Mucinous Tubular and Spindle Cell Carcinoma of the Kidney: A Case Report
por: Chrysikos, Dimosthenis, et al.
Publicado: (2012)

Development and Validation of Ovarian Symptom Index-18 and Neurotoxicity-4 for Korean Patients with Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
por: Lee, Maria, et al.
Publicado: (2019)

Tumorigenesis and peritoneal colonization from fallopian tube epithelium
por: Eddie, Sharon L., et al.
Publicado: (2015)

Aggressive surgery could overcome the extent of initial peritoneal dissemination for advanced ovarian, fallopian tube, and peritoneal carcinoma
por: Nishikimi, Kyoko, et al.
Publicado: (2020)

Second primary cancer after primary peritoneal, epithelial ovarian, and fallopian tubal cancer: a retrospective study
por: Lim, Myong Cheol, et al.
Publicado: (2018)

Phase II of oral gimatecan in patients with recurrent epithelial ovarian, fallopian tube or peritoneal cancer, previously treated with platinum and taxanes
por: Pecorelli, S., et al.
Publicado: (2010)

The role of high-dose chemotherapy in the treatment of testicular cancer
por: Karadimou, Alexandra, et al.
Publicado: (2010)

A phase II study of the combination chemotherapy of bevacizumab and gemcitabine in women with platinum-resistant recurrent epithelial ovarian, primary peritoneal, or fallopian tube cancer
por: Nagao, Shoji, et al.
Publicado: (2020)

Modulated electro-hyperthermia with weekly paclitaxel or cisplatin in patients with recurrent or persistent epithelial ovarian, fallopian tube or primary peritoneal carcinoma: The KGOG 3030 trial
por: Kim, Kidong, et al.
Publicado: (2021)

High visceral fat-to-muscle ratio is an independent factor that predicts worse overall survival in patients with primary epithelial ovarian, fallopian tube, and peritoneal cancer
por: Ham, Sooji, et al.
Publicado: (2023)

Reconstitution of high-grade serous ovarian carcinoma from primary fallopian tube secretory epithelial cells
por: Nakamura, Kohei, et al.
Publicado: (2017)

The Safety and Efficacy of Laparoscopic Surgical Staging and Debulking of Apparent Advanced Stage Ovarian, Fallopian Tube, and Primary Peritoneal Cancers
por: Nezhat, Farr R., et al.
Publicado: (2010)

Prevalence of Tissue BRCA Gene Mutation in Ovarian, Fallopian Tube, and Primary Peritoneal Cancers: A Multi-Institutional Study
por: Lertkhachonsuk, Arb-Aroon, et al.
Publicado: (2020)

The 2020 Japan Society of Gynecologic Oncology guidelines for the treatment of ovarian cancer, fallopian tube cancer, and primary peritoneal cancer
por: Tokunaga, Hideki, et al.
Publicado: (2021)

Phase Ib Study of Navicixizumab Plus Paclitaxel in Patients With Platinum-Resistant Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
por: Fu, Siqing, et al.
Publicado: (2022)

Volume of blood suctioned during vacuum-assisted breast biopsy predicts later hematoma formation
por: Zagouri, Flora, et al.
Publicado: (2010)

Breast ductal endoscopy: how many procedures qualify?
por: Zagouri, Flora, et al.
Publicado: (2009)

Ex Vivo Culture of Primary Human Fallopian Tube Epithelial Cells
por: Fotheringham, Susan, et al.
Publicado: (2011)

Pembrolizumab with low-dose carboplatin for recurrent platinum-resistant ovarian, fallopian tube, and primary peritoneal cancer: survival and immune correlates
por: Liao, John B, et al.
Publicado: (2021)

Early transcriptional response of human ovarian and fallopian tube surface epithelial cells to norepinephrine
por: Gjyshi, Anxhela, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_taak7p552u21156eqql3ju5iji